These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 90129)

  • 41. Suppression of experimental allergic encephalomyelitis by alpha 2-macroglobulin.
    Hunter N; Weston KM; Bowern NA
    Immunology; 1991 May; 73(1):58-63. PubMed ID: 1710603
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chronic-relapsing experimental autoimmune encephalomyelitis. Myelin basic protein induces suppression of blastogenesis during remissions but not during exacerbations.
    Lyman WD; Brosnan CF; Raine CS
    J Neuroimmunol; 1985; 7(5-6):345-53. PubMed ID: 2579093
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A new pattern of spinal-cord demyelination in guinea pigs with acute experimental allergic encephalomyelitis mimicking multiple sclerosis.
    Colover J
    Br J Exp Pathol; 1980 Aug; 61(4):390-400. PubMed ID: 7426390
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chronic relapsing experimental allergic encephalomyelitis in the Lewis rat.
    Feurer C; Prentice DE; Cammisuli S
    J Neuroimmunol; 1985 Dec; 10(2):159-66. PubMed ID: 3877741
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oral tolerance in experimental autoimmune encephalomyelitis: specificity of peptide-induced oral tolerance.
    Javed NH; Gienapp I; Cox K; Whitacre CC
    Ann N Y Acad Sci; 1996 Feb; 778():393-4. PubMed ID: 8611001
    [No Abstract]   [Full Text] [Related]  

  • 46. Liposomes containing myelin basic protein (BP) suppress but do not induce allergic encephalomyelitis in Lewis rats.
    Willenborg DO; Higgins TJ
    Aust J Exp Biol Med Sci; 1981 Apr; 59(Pt 2):135-41. PubMed ID: 6167253
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Experimental allergic encephalomyelitis induced by basic protein with synthetic adjuvant in comparison with Freund's complete adjuvant. Role of antibodies in correlation with the clinicopathological features.
    Mitsuzawa E; Yasuda T; Tamura N; Ohtani S
    J Neurol Sci; 1981 Oct; 52(1):133-45. PubMed ID: 6170738
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influence of cerebroside and ganglioside on the encephalitogenic activity of myelin basic protein in guinea pigs.
    Brinkman CJ; ter Laak HJ; Hommes OR
    Acta Neurol Scand; 1983 Mar; 67(3):143-50. PubMed ID: 6191512
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immune protection against experimental autoimmune encephalomyelitis: optimal conditions and analysis of mechanism.
    Coates A; Mackay IR; Crawford M
    Cell Immunol; 1974 Jun; 12(3):370-81. PubMed ID: 4142423
    [No Abstract]   [Full Text] [Related]  

  • 50. Delayed, relapsing experimental allergic encephalomyelitis in mice. Role of adjuvants and pertussis vaccine.
    Lublin FD
    J Neurol Sci; 1982; 57(1):105-10. PubMed ID: 7153781
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the Lewis rat and strain 13 guinea pig.
    Brod SA; al-Sabbagh A; Sobel RA; Hafler DA; Weiner HL
    Ann Neurol; 1991 Jun; 29(6):615-22. PubMed ID: 1716432
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Peptide length requirement for experimental allergic encephalomyelitis in guinea pigs.
    Levit S; Powers JM; Milek D; Brostoff SW
    Neurochem Res; 1980 Jan; 5(1):37-42. PubMed ID: 6154250
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vivo immunomodulation by monoclonal anti-CD4 antibody. II. Effect on T cell response to myelin basic protein and experimental allergic encephalomyelitis.
    Sriram S; Carroll L; Fortin S; Cooper S; Ranges G
    J Immunol; 1988 Jul; 141(2):464-8. PubMed ID: 2454992
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Autoimmunity in multiple slcerosis: do we have an experimental model?
    Kies MW
    Adv Exp Med Biol; 1978; 100():277-88. PubMed ID: 80941
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Experimental allergic encephalomyelitis (EAE) in two inbred guinea pigs: 1. Strain differences in developing chronic relapsing form of EAE.
    Fujiwara S; Ohtani S
    Jpn J Exp Med; 1980 Jun; 50(3):173-8. PubMed ID: 7001094
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro response to basic protein in experimental allergic encephalomyelitis: effect of pretreatment with basic protein in incomplete adjuvant.
    Lisak RP; Zweiman B; Dzida L; Rosenblum F; Rorke LB; Barger G
    Cell Immunol; 1980 Jul; 52(2):443-50. PubMed ID: 6159988
    [No Abstract]   [Full Text] [Related]  

  • 57. Protection against experimental allergic encephalomyelitis with complete Freund's adjuvant is unaffected by ionizing irradiation.
    Weber F; Hempel K
    Int Arch Allergy Appl Immunol; 1987; 83(2):174-7. PubMed ID: 2438218
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical suppression of experimental allergic encephalomyelitis by muramyl dipeptide "adjuvant".
    Root-Bernstein RS; Yurochko F; Westall FC
    Brain Res Bull; 1986 Oct; 17(4):473-6. PubMed ID: 3779448
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of Freund's adjuvants on blood-cerebrospinal fluid barrier permeability.
    Reiber H; Suckling AJ; Rumsby MG
    J Neurol Sci; 1984 Jan; 63(1):55-61. PubMed ID: 6699654
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enzymatic changes in various organs of guinea pigs caused by the administration of Freund's complete adjuvant.
    Aoyagi T; Wada T; Nishikiori T; Kojima F; Nagai M; Osanai T; Nagai Y; Umezawa H
    J Pharmacobiodyn; 1983 Dec; 6(12):974-82. PubMed ID: 6201605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.